EMA

RSS

CHMP recommends Merck, Sharp and Dohme's Ivemend for nausea with chemotherapy

Nov. 21, 2007

Abbott voluntarily withdraws E.U. marketing authorization for Trudexa

Aug. 1, 2007

Bausch & Lomb Ireland withdraws Retisert marketing authorization application

July 27, 2007

Rasilez recommended for E.U. approval

June 25, 2007

Orlistat GSK recommended for approval in E.U.

June 1, 2007

Protherics withdraws European application for Voraxaze

May 31, 2007

European CHMP recommends approval of Siklos

May 10, 2007

Pergoveris recommended for E.U. approval

May 9, 2007

Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma

April 11, 2007

Lilly withdraws E.U. marketing authorization application for Arxxant

April 10, 2007